ATE515491T1 - Herstellung von 3-ä(1r,2r)-3-(dimethylamino)- 1ethyl-2-methylpropylüphenol - Google Patents

Herstellung von 3-ä(1r,2r)-3-(dimethylamino)- 1ethyl-2-methylpropylüphenol

Info

Publication number
ATE515491T1
ATE515491T1 AT07786259T AT07786259T ATE515491T1 AT E515491 T1 ATE515491 T1 AT E515491T1 AT 07786259 T AT07786259 T AT 07786259T AT 07786259 T AT07786259 T AT 07786259T AT E515491 T1 ATE515491 T1 AT E515491T1
Authority
AT
Austria
Prior art keywords
methylpropyl
dimethylamino
preparation
phenol
1ethyl
Prior art date
Application number
AT07786259T
Other languages
English (en)
Inventor
Wolfgang Hell
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of ATE515491T1 publication Critical patent/ATE515491T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/20Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C219/22Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT07786259T 2006-07-24 2007-07-23 Herstellung von 3-ä(1r,2r)-3-(dimethylamino)- 1ethyl-2-methylpropylüphenol ATE515491T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06015317 2006-07-24
PCT/EP2007/006514 WO2008012046A1 (en) 2006-07-24 2007-07-23 Preparation of 3-[(1r,2r)-3-(dimethylamino)-1ethyl-2-methylpropyl]phenol

Publications (1)

Publication Number Publication Date
ATE515491T1 true ATE515491T1 (de) 2011-07-15

Family

ID=37492362

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07786259T ATE515491T1 (de) 2006-07-24 2007-07-23 Herstellung von 3-ä(1r,2r)-3-(dimethylamino)- 1ethyl-2-methylpropylüphenol

Country Status (23)

Country Link
US (1) US8263809B2 (de)
EP (1) EP2049464B1 (de)
JP (1) JP5357756B2 (de)
KR (1) KR101433685B1 (de)
CN (1) CN101495446B (de)
AT (1) ATE515491T1 (de)
AU (1) AU2007278463B2 (de)
BR (1) BRPI0714648B8 (de)
CA (1) CA2658648C (de)
CY (1) CY1111829T1 (de)
DK (1) DK2049464T3 (de)
ES (1) ES2366390T3 (de)
HR (1) HRP20110572T1 (de)
IL (1) IL196626A (de)
MX (1) MX2008016380A (de)
NO (1) NO341683B1 (de)
NZ (1) NZ573906A (de)
PL (1) PL2049464T3 (de)
RU (1) RU2463290C2 (de)
SI (1) SI2049464T1 (de)
TW (1) TWI401237B (de)
WO (1) WO2008012046A1 (de)
ZA (1) ZA200901279B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009000911A (es) * 2006-07-24 2009-02-04 Janssen Pharmaceutica Nv Preparacion de (2r,3r)-3-(3-metoxifenil)-n,n,2-trimetilpentanamina .
CA2739936C (en) 2008-10-17 2017-12-12 Pharmacofore, Inc. Pharmaceutical compositions with attenuated release of phenolic opioids
CN102002065B (zh) * 2009-09-02 2014-09-10 上海特化医药科技有限公司 他喷他多的制备方法及其中间体
US8288592B2 (en) * 2009-09-22 2012-10-16 Actavis Group Ptc Ehf Solid state forms of tapentadol salts
IT1397189B1 (it) * 2009-12-01 2013-01-04 Archimica Srl Nuovo processo per la preparazione di tapentadol e suoi intermedi.
WO2011080756A1 (en) * 2009-12-29 2011-07-07 Ind-Swift Laboratories Limited Process for the preparation of 1-phenyl-3-dimethylaminopropane derivatives
US20130096346A1 (en) 2010-03-05 2013-04-18 Actavis Group Ptc Ehf Resolution methods for isolating desired enantiomers of tapentadol intermediates and use thereof for the preparation of tapentadol
WO2011128784A2 (en) 2010-04-05 2011-10-20 Actavis Group Ptc Ehf Novel process for preparing highly pure tapentadol or a pharmaceutically acceptable salt thereof
WO2011133348A1 (en) 2010-04-21 2011-10-27 Pharmacofore, Inc. Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof
US20110262355A1 (en) 2010-04-21 2011-10-27 Jenkins Thomas E Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
US9238020B2 (en) 2010-04-21 2016-01-19 Signature Therapeutics, Inc. Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug
ITMI20100924A1 (it) * 2010-05-21 2011-11-22 Fidia Farmaceutici Nuovo metodo di sintesi delle due forme enantiomeriche del tapentadol
CN103168025B (zh) * 2010-06-15 2015-02-25 格吕伦塔尔有限公司 用于制备取代的3-(1-氨基-2-甲基戊烷-3-基)苯基化合物的方法
IT1401109B1 (it) * 2010-07-02 2013-07-12 Archimica Srl Nuovo processo per la preparazione di tapentadol e suoi intermedi.
ES2860676T3 (es) * 2010-07-23 2021-10-05 Gruenenthal Gmbh Sales o cocristales de 3- (3-dimetilamino-1-etil-2-metil-propil) -fenol
EP2606030B1 (de) * 2010-08-16 2016-05-18 Indoco Remedies Limited Verfahren zur herstellung von tapentadol
US8552219B2 (en) 2010-09-20 2013-10-08 Ind-Swift Laboratories Limited Process for preparing L-phenyl-3-dimethylaminopropane derivative
HUP1300623A2 (en) * 2010-12-30 2014-03-28 Zentiva Ks O-substituted (2r,3r)-3-(3-hidroxiphenil)-2-metyil-4-pentenoic acids and a method of obtaining the same
WO2012096887A2 (en) 2011-01-11 2012-07-19 Signature Therapeutics, Inc. Compositions comprising enzyme-cleavable oxycodone prodrug
WO2012101649A1 (en) 2011-01-27 2012-08-02 Symed Labs Limited A novel stereospecific synthesis of (-) (2s,3s)-1-dimethylamino-3-(3-methoxyphenyl)-2-methyl pentan-3-ol
CN102617501A (zh) 2011-01-31 2012-08-01 中国科学院上海药物研究所 取代正戊酰胺类化合物、其制备方法及用途
MX369121B (es) * 2011-03-04 2019-10-30 Gruenenthal Gmbh Formulacion farmaceutica acuosa de tapentadol para administracion oral.
AU2012225337B2 (en) 2011-03-09 2016-04-28 Signature Therapeutics, Inc. Active agent prodrugs with heterocyclic linkers
WO2012146978A2 (en) 2011-04-28 2012-11-01 Actavis Group Ptc Ehf A novel process for the preparation of tapentadol or a pharmaceutically acceptable salt thereof
WO2013105109A1 (en) 2011-11-09 2013-07-18 Indoco Remedies Limited Process for the preparation of tapentadol
US20130150622A1 (en) 2011-12-12 2013-06-13 Boehringer Ingelheim International Gmbh Stereoselective synthesis of tapentadol and its salts
WO2013120466A1 (en) 2012-02-17 2013-08-22 Zentiva, K.S. A new solid form of tapentadol and a method of its preparation
EP2674414A1 (de) 2012-06-15 2013-12-18 Siegfried AG Verfahren zur Herstellung von 1-aryl-1-alkyl-3-dialkylaminopropan-Verbindungen
CN103159633B (zh) * 2012-07-06 2015-08-12 江苏恩华药业股份有限公司 他喷他多的制备方法及用于制备他喷他多的化合物
CN102924303B (zh) * 2012-10-31 2013-11-20 合肥市新星医药化工有限公司 盐酸他喷他多晶型c及其制备方法和应用
WO2014141296A2 (en) * 2013-03-09 2014-09-18 Ind-Swift Laboratories Limited Process for the preparation of tapentadol via novel intermediate
IN2013MU03478A (de) * 2013-11-01 2015-07-17 Sun Pharma Advanced Res Co Ltd
CN103553940A (zh) * 2013-11-07 2014-02-05 南京艾德凯腾生物医药有限责任公司 一种新晶型盐酸他喷他多的制备方法
IN2013MU03670A (de) 2013-11-21 2015-07-31 Unimark Remedies Ltd
SI3083551T1 (en) 2013-12-16 2018-04-30 Farma Grs, D.O.O. CRYSTAL FORM INTERMEDIATE TAPENTADOL
CZ307492B6 (cs) 2014-02-04 2018-10-17 Zentiva, K.S. Pevná forma maleátu tapentadolu a způsob její přípravy
WO2016007823A1 (en) 2014-07-10 2016-01-14 Mallinckrodt Llc Process for preparing substituted phenylalkanes
CA2991421C (en) 2015-07-10 2019-04-30 Mallinckrodt Llc A two-step process for preparing 3-substituted phenylalkylamines
SK812017A3 (sk) 2017-08-18 2019-03-01 Saneca Pharmaceuticals A. S. Spôsob prípravy tapentadolu a jeho medziproduktov
EP3947342A4 (de) 2019-03-28 2022-12-28 Council of Scientific and Industrial Research Neues verfahren zur herstellung von tapentadol und zwischenprodukten draus
MX2023010506A (es) 2021-03-09 2023-09-20 Ensysce Biosciences Inc Composiciones que comprenden profarmacos de escision enzimatica y nafamostat de liberacion controlada y metodos de uso de estos.
EP4116288A1 (de) 2021-07-08 2023-01-11 KRKA, d.d., Novo mesto Racemisierung von (s) und/oder (r)-3-(dimethylamino)-1-(3-methoxyphenyl)-2-methylpropan-1-on und mischungen davon
CA3230025A1 (en) 2021-09-29 2023-04-06 Lynn Kirkpatrick Enzyme-cleavable methadone prodrugs and methods of use thereof
CN119192000B (zh) * 2024-11-26 2025-07-15 苏州盛迪亚生物医药有限公司 连续流反应制备他喷他多或其可药用盐的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
JP4202327B2 (ja) * 1996-04-09 2008-12-24 ヤマサ醤油株式会社 1−(2−デオキシ−2−フルオロ−4−チオ−β−D−アラビノフラノシル)シトシン
DE19805370A1 (de) * 1997-03-14 1998-09-17 Gruenenthal Gmbh Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen
US6399828B1 (en) * 2001-10-29 2002-06-04 Boehringer Ingelheim Chemicals, Inc. Preparation of amphetamines from phenylpropanolamines
DE10326097A1 (de) 2003-06-06 2005-01-05 Grünenthal GmbH Verfahren zur Herstellung von Dimethyl-(3-aryl-butyl)-aminverbindungen
DE10328316A1 (de) 2003-06-23 2005-01-20 Grünenthal GmbH Verfahren zur Herstellung von Dimethyl-(3-aryl-buthyl)-aminverbindungen als pharmazeutische Wirkstoffe
MX2009000911A (es) * 2006-07-24 2009-02-04 Janssen Pharmaceutica Nv Preparacion de (2r,3r)-3-(3-metoxifenil)-n,n,2-trimetilpentanamina .

Also Published As

Publication number Publication date
MX2008016380A (es) 2009-01-30
RU2463290C2 (ru) 2012-10-10
DK2049464T3 (da) 2011-08-15
NZ573906A (en) 2011-04-29
BRPI0714648B1 (pt) 2021-02-02
CN101495446B (zh) 2012-12-05
BRPI0714648B8 (pt) 2021-05-25
NO20090691L (no) 2009-02-23
PL2049464T3 (pl) 2011-11-30
HK1130247A1 (en) 2009-12-24
JP2009544637A (ja) 2009-12-17
ZA200901279B (en) 2010-02-24
CY1111829T1 (el) 2015-10-07
RU2009106169A (ru) 2010-08-27
EP2049464A1 (de) 2009-04-22
BRPI0714648A2 (pt) 2013-05-07
NO341683B1 (no) 2017-12-18
WO2008012046A1 (en) 2008-01-31
AU2007278463B2 (en) 2011-11-24
US8263809B2 (en) 2012-09-11
IL196626A (en) 2013-07-31
ES2366390T3 (es) 2011-10-19
JP5357756B2 (ja) 2013-12-04
CN101495446A (zh) 2009-07-29
EP2049464B1 (de) 2011-07-06
KR20090035003A (ko) 2009-04-08
SI2049464T1 (sl) 2011-10-28
CA2658648A1 (en) 2008-01-31
KR101433685B1 (ko) 2014-08-25
AU2007278463A1 (en) 2008-01-31
HRP20110572T1 (hr) 2011-09-30
IL196626A0 (en) 2009-11-18
CA2658648C (en) 2014-02-25
TW200815317A (en) 2008-04-01
US20090326271A1 (en) 2009-12-31
TWI401237B (zh) 2013-07-11

Similar Documents

Publication Publication Date Title
NO20090691L (no) Fremstilling av 3-[(1R,2R)-3-(dimetylamino)-1-etyl-2-metylpropyl]fenol
NO20171811A1 (no) Fremgangsmåte for fremstilling av (1R,2R)-3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol
ATE455752T1 (de) Herstellung von (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpent namin
TW200626171A (en) Fixed dosing of HER antibodies
CY1122416T1 (el) Φαρμακα τα οποια περιεχουν κρυσταλλικες τροποποιησεις (1r,2r)-3-(3-δimeθyλamino-1-αιθυλο-2-μεθυλο-προπυλο)-φαινολης
IT1394472B1 (it) Tavolo per riunioni.
MX2007005936A (es) Una sintesis asimetrica del acido (s)-(+)-3-(aminometil)-5- metilhexanoico.
WO2008104957A3 (en) Novel polymorphic forms of milnacipran hydrochloride

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2049464

Country of ref document: EP